/Investor DB

Ambit Health Ventures — 2022 Investments

2 investments dated 2022 · listed companies and verified rows first · show all

WAVELY DIAGNOSTICSwavelydx.comin𝕏Pre-Seed · Jul 2022 · $2M

WavelyDx offers an FDA-listed acoustic scanning device and companion smartphone app that lets parents check their child's ears at home for signs of an ear infection.

AI & Machine LearningDigital HealthHealthtechMedical DevicesSeattle, US

Shyamnath Gollakota(Director, Promoter)Randall Bly(Director, Promoter)inArna Ionescu Stoll(Chief Executive Officer)inJacob Reider(Chief Health, Privacy, & Security Officer)inJoe Cotellese(VP of Technology)inJud Heugel(Executive Officer)

Co-investorsGaingelsHealthtech CapitalLong Way VenturesRobin Hood VenturesSymphonic CapitalWealthing VC Club+2 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

SOAP Health

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.